Advanced Energy Industries Inc (NASDAQ: AEIS) saw an insider sale this month as director Anne DelSanto disposed of 240 shares on March 16, 2026, at $312.59 per share, according to a Securities and Exchange Commission filing. The trade totaled $75,021. After the transaction, DelSanto retains direct ownership of 6,414 shares held through The Delsanto Family Trust.
The disposition was carried out under a Rule 10b5-1 trading plan that DelSanto adopted on March 13, 2025. At the time of the filing, the stock had continued a notable advance, trading at $320.63 and reflecting a roughly 200% gain over the last 12 months.
Separately, Advanced Energy reported strong operating results for the fourth quarter of 2025, beating consensus on both the top and bottom lines. The company posted earnings per share of $1.94, above the $1.78 estimate, and reported revenue of $489 million versus a projected $473.11 million. Management highlighted year-over-year revenue growth of 18% and EPS that came in 9% ahead of consensus.
Those results prompted analyst action. Needham raised its price target to $330 from $290 and maintained a Buy rating, citing the company’s stronger-than-expected quarterly performance. TD Cowen also increased its target, moving it from $210 to $300 and pointed to semiconductor strength as an important contributor to the quarter and the near-term outlook.
On the product front, Advanced Energy introduced the LPP200 series, a family of 200-watt AC-DC power supplies intended for medical and industrial end markets. The company characterized the launch as part of its ongoing product development efforts, aligning new offerings with application-driven demand.
Context and implications - The insider sale was executed under a pre-arranged plan and does not change the director’s remaining holdings through the family trust. At the same time, the company’s quarterly performance, analyst upgrades, and a targeted product introduction together underscore momentum across both commercial execution and market reception. The semiconductor sector and medical and industrial equipment markets were cited directly in analyst commentary and product positioning.